Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair.

At week 2, EF and FS were higher in the mESC-CM only and mESC-CM+PA-RGDS groups compared to the PA-RGDS only and PBS groups, although the differences did not reach statistical significance.

also in 111,027 other papers